Indeed, serum HSP90α level was increased with the tumor growth of CAF-involved PDAC cell grafts in mice, and OG treatment significantly suppressed such elevation of the serum HSP90α level (Figure 5G). The gene discussed is HSP90AA1; the disease is neoplasm.